Physician profile
Salman Chohan
NPI 1023305638
$7,180.13
in general payments reported to CMS, 2019-2025
48 companies · $1,529 in 2025
The $1,529 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $236 · 2021: $891 · 2022: $1,336 · 2023: $1,497 · 2024: $1,590 · 2025: $1,529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,504 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,504.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $111.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $768.80 | 2022-2025 | Botox, Lupron Depot |
| Janssen Biotech, INC. | $602.53 | 2021-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $522.80 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $522.73 | 2021-2025 | |
| Endo Pharmaceuticals INC. | $354.50 | 2020-2024 | Aveed, Xiaflex, Edex |
| Astellas Pharma US INC | $315.30 | 2020-2025 | Xtandi, Veozah |
| Teleflex LLC | $274.57 | 2021-2025 | Urolift |
| Urogen Pharma, INC. | $270.05 | 2022-2025 | Jelmyto |
| Progenics Pharmaceuticals, INC. | $255.60 | 2022-2025 | |
| Medtronic, INC. | $228.60 | 2022-2023 | Interstim |
| Accord Healthcare, INC. | $220.88 | 2023-2025 | |
| Olympus America INC. | $212.34 | 2023-2025 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $188.85 | 2021-2025 | |
| Amgen INC. | $171.20 | 2020-2023 | Prolia |
| Myriad Genetic Laboratories, INC. | $166.28 | 2021-2024 | Prolaris |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $162.60 | 2025 | |
| Antares Pharma, INC. | $151.70 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Coloplast Corp | $150.85 | 2019-2024 | Speedicath |
| Ferring Pharmaceuticals INC. | $135.47 | 2024-2025 | Adstiladrin |
| Novartis Pharmaceuticals Corporation | $125.93 | 2023-2025 | |
| Urovant Sciences INC | $114.49 | 2021-2022 | |
| Endo USA, INC. | $109.60 | 2024-2025 | Xiaflex, Aveed |
| Myovant Sciences INC. | $107.16 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $93.44 | 2022-2025 | Provenge |
| Tolmar Pharmaceuticals, INC. | $92.43 | 2021-2022 | |
| Blue Earth Diagnostics | $84.85 | 2020-2024 | |
| Lantheus Medical Imaging, INC. | $76.13 | 2024 | |
| Allergan, INC. | $71.14 | 2021-2022 | |
| Bioprotect Medical, INC. | $69.19 | 2025 | Bioprotect Balloon Implant System |
| Caris Mpi, INC. | $58.33 | 2025 | Mi Cancer Seek |
| Merck Sharp & Dohme LLC | $54.81 | 2022-2023 | Welireg, Keytruda, Lynparza |
| Tempus Ai, INC | $42.89 | 2024 | Xt Cdx |
| Astrazeneca Pharmaceuticals Lp | $41.00 | 2021-2022 | |
| Boston Scientific Corporation | $37.65 | 2021-2025 | Rezum Generator |
| Clarus Therapeutics INC. | $29.39 | 2021 | |
| Convatec INC. | $27.25 | 2021 | |
| Alexion Pharmaceuticals, INC. | $26.56 | 2022 | |
| Axonics, INC. | $26.49 | 2023 | Axonics |
| Laborie Medical Technologies Corp. | $26.36 | 2025 | Endosheath Technology |
| Sobi, INC | $25.59 | 2020 | |
| Novo Nordisk INC | $22.52 | 2024 | Rivfloza |
| Cook Medical LLC | $22.36 | 2025 | Litho 150 |
| Tolmar, INC. | $21.29 | 2023 | |
| Halozyme INC | $21.05 | 2023 | |
| Therapeuticsmd, INC. | $20.83 | 2021 | |
| Photocure INC | $20.59 | 2024 | Cysview |
| Dentsply Ih INC. | $18.59 | 2021 | |
| 180 Medical, INC. | $16.57 | 2024 | Cure Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salman Chohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.